Anupendra Sharma is Partner at Siemens Venture Capital investing in healthcare (devices, diagnostics, software and services). Anupendra is an investor in BioImagene, China Diagnostics and Cylex. He is a former investor in Sequenom (NASD: SQNM).
As Anupendra is based in the U.S., he is an employee of Siemens Financial Services, Inc. and may not provide investment advice to any third parties.
Prior to Siemens Venture Capital, Anupendra helped companies go public and raise capital, and completed $5 billion in M&A transactions at JPMorgan, Salomon Smith Barney and Siemens. Anupendra also worked in strategy consulting for McKinsey London, and Product Development Finance for Ford Europe, where he was a member of the core team that set-up Ford in China and India.
Anupendra founded several companies and not-for profits including Mobile Medics, named the Most Innovative Social Venture of 2006 by the Global Social Venture Competition for attempting to solve the “last-mile” problem for global rural healthcare.
Anupendra is a Charter Member of TiE Boston, Founder of the TiE Leadership Program for Entrepreneurial CEOs of the future, and advisor to to early-stage life sciences efforts in New England. Anupendra founded the Center for Entrepreneurial Leadership at BITS Pilani, and is Founding Advisor to Peking University's Venture Capital Association. He also started the Massachusetts Life Sciences Startup Initiative, to accelerate the pace of startups in the Commonwealth, and advises government and related agencies on policy matters related to startups in the Commonwealth.
Anupendra holds an MBA from Cornell University, MS in Accounting & Finance from Manchester Business School, Masters in Economics and Bachelors in Instrumentation Engineering from BITS Pilani, India.